FOXM1 and breast cancer: Furthermore, FOXM1 has been used as a key drug target in breast cancer [49,50], and several drugs (e.g., daunorubicin, doxorubicin, epirubicin, and tamoxifen [51]) developed to target or inhibit FOXM1 have been tested in clinical trials (https://clinicaltrials.gov/).